Cargando…

A NFAT decoy approach to inhibit cardiac hypertrophy

Detalles Bibliográficos
Autor principal:	Heineke, Joerg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599344/ https://www.ncbi.nlm.nih.gov/pubmed/34767041 http://dx.doi.org/10.1007/s00424-021-02637-9

Ejemplares similares

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

Targeting cardiac hypertrophy through a nuclear co‐repressor
por: Grund, Andrea, et al.
Publicado: (2019)

How does NFAT3 regulate the occurrence of cardiac hypertrophy?
por: Hui, Wang, et al.
Publicado: (2023)

Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
por: Li, Xiurong, et al.
Publicado: (2017)

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling
por: Verma, Nirmal, et al.
Publicado: (2021)

GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2016)

CIB1 is a Regulator of Pathological Cardiac Hypertrophy
por: Heineke, Joerg, et al.
Publicado: (2010)

Decoy fitness peaks, tumor suppression, and aging
por: Higa, Kelly C., et al.
Publicado: (2019)

YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy
por: Xu, Hongfei, et al.
Publicado: (2021)

Inhibiting an inhibitor: a decoy to recover dexterity after spinal cord injury
por: Bradbury, Elizabeth J, et al.
Publicado: (2020)

Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
por: Chang, Tzu-Hao, et al.
Publicado: (2016)

Decoy Receptors in the Regulation of T Helper Cell Type 2 Responses
por: McKenzie, Andrew N.J., et al.
Publicado: (2003)

Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
por: Eitner, Fiona, et al.
Publicado: (2022)

Integrated decoys and effector traps: how to catch a plant pathogen
por: Ellis, Jeffrey G.
Publicado: (2016)

Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
por: Luo, Yuxuan, et al.
Publicado: (2021)

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
por: Xiao, Lili, et al.
Publicado: (2017)

Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
por: Lunde, Ida G., et al.
Publicado: (2022)

Neutrophil extracellular traps in cardiac hypertrophy: a KLF2 perspective
por: Riascos-Bernal, Dario F., et al.
Publicado: (2022)

Effects of miR-939 and miR-376A on ulcerative colitis using a decoy strategy to inhibit NF-κB and NFAT expression
por: Lin, Yongwei, et al.
Publicado: (2022)

TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
por: Grund, Andrea, et al.
Publicado: (2019)

A novel RIT1 mutation causes deterioration of Noonan syndrome-associated cardiac hypertrophy
por: Cai, Jingjing, et al.
Publicado: (2019)

Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
por: Bernt, Alexander, et al.
Publicado: (2016)

Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells
por: Kim, Dong Hyun, et al.
Publicado: (2021)

The Prevention Role of Theaflavin-3,3′-digallate in Angiotensin II Induced Pathological Cardiac Hypertrophy via CaN-NFAT Signal Pathway
por: Zhou, Hui, et al.
Publicado: (2022)

FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
por: Böckmann, Ineke, et al.
Publicado: (2019)

Calcineurin/NFAT signalling inhibits myeloid haematopoiesis
por: Fric, Jan, et al.
Publicado: (2012)

Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
por: Loyer, Xavier, et al.
Publicado: (2019)

DecoyFinder, a tool for finding decoy molecules
por: Adrià, Cereto Massagué, et al.
Publicado: (2012)

Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting PGC-1alpha
por: Yan, Hualin, et al.
Publicado: (2020)

Autoantibody:Autoantigen Competitor Decoys: Application to Cardiac Phenotypes
por: Cardozo, Timothy, et al.
Publicado: (2022)

Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway
por: Finsen, Alexandra V., et al.
Publicado: (2011)

Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
por: Yoon, Jung Joo, et al.
Publicado: (2020)

TNF-α signaling: TACE inhibition to put out the burning heart
por: Dittrich, Gesine M., et al.
Publicado: (2020)

The Potential Role of NFAT5 and Osmolarity in Peritoneal Injury
por: Seeger, Harald, et al.
Publicado: (2015)

Circ_0001944 Contributes to Glycolysis and Tumor Growth by Upregulating NFAT5 Through Acting as a Decoy for miR-142-5p in Non-Small Cell Lung Cancer
por: Dou, Yawei, et al.
Publicado: (2021)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
por: Denichenko, Polina, et al.
Publicado: (2019)

Cardiac forces regulate zebrafish heart valve delamination by modulating Nfat signaling
por: Chow, Renee Wei-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mets6f1pg6u9ur9bkmq1i5emf2